title: Letter from the editor.
authors: Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
authors: Ronald
authors: R
authors: Ellis
authors: Eva M
authors: EM
authors: Riedmann
mesh_terms: D001428:Bacterial Vaccines / Q000191:economics / Q000276:immunology* / Q000302:isolation & purification*; D056808:Biostatistics / Q000379:methods; D003365:Costs and Cost Analysis; D004812:Epidemiologic Methods; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D016896:Treatment Outcome; D014765:Viral Vaccines / Q000191:economics / Q000276:immunology* / Q000302:isolation & purification*
chemical_list: D001428:Bacterial Vaccines; D014765:Viral Vaccines